As of December 2024, the company held about $1.2 billion of cash and ... Since purchasing Solexa with its Genome Reader instrument in 2007, Illumina’s continued innovation significantly reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback